Apyx Medical Corporation (APYX) vs Black Diamond Therapeutics, Inc. (BDTX)
A side-by-side comparison of Apyx Medical Corporation and Black Diamond Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APYX
Apyx Medical Corporation
$2.62HealthcareDelayed quote: Oct 6, 2026, 2:17 PM EDT
BDTX
Black Diamond Therapeutics, Inc.
$1.81HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — APYX vs BDTX
growth of $100 · dividends reinvested · last 7yAPYX -65.7% (-14.2%/yr)BDTX -95.1% (-35.0%/yr)APYX compounded faster over this window
Log scale — wide-divergence pair
APYX BDTX
APYX vs BDTX: by the numbers
- •APYX is the larger company ($110M vs $103M market cap).
- •BDTX is profitable (31.95% net margin) while APYX runs a net loss (-14.78%).
Metrics side by side
Valuation
| Metric | APYX | BDTX |
|---|---|---|
| P/S ratio | 1.89 | N/A |
| P/B ratio | 10.33 | 1.08 |
Profitability
| Metric | APYX | BDTX |
|---|---|---|
| Gross margin | 33.94% | 99.54% |
| Operating margin | -6.06% | 28.39% |
| Net margin | -14.78% | 31.95% |
| ROE | -80.97% | -44.29% |
| ROIC | -6.84% | -47.54% |
Growth (annualized)
| Metric | APYX | BDTX |
|---|---|---|
| Revenue CAGR (5Y) | 8.82% | N/A |
| Total return CAGR (5Y) | -28.10% | -24.47% |
Frequently asked
- Is APYX or BDTX more profitable?
- BDTX runs the higher net margin — APYX at -14.78% versus BDTX at 31.95%.
- How have APYX and BDTX total returns compared?
- Over the past 5 years, APYX delivered -28.10% and BDTX delivered -24.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.